Research: Midkine Controls Arteriogenesis by Regulating VEGFA Bioavailability and NOS Expression, page-3

Mighty, I have seen and read more midkine papers with positive research to occupy an entire to row of text books at the New York City library.

Without a commercial deal behind any of the research we all know it means sweet FA for shareholders.

The question needs to be asked why hasn’t this happened?

- does big pharma want a bigger slice of the cake than Cellmid is willing to cut?
- maybe the cake looks enticing but no one is willining to try it?
- or other possibilities ?

Either way midkine needs to commercialised with real money instead of being talked about like the amazing holy grail that slipped away.